key: cord-1018712-kfaegi46 authors: Jekarl, Dong Wook; Lee, Seungok; Kim, Myungshin; Kim, Yonggoo; Woo, Seon Hee; Lee, Woon Jeong title: Procalcitonin as a prognostic marker for sepsis based on SEPSIS‐3 date: 2019-08-16 journal: J Clin Lab Anal DOI: 10.1002/jcla.22996 sha: 74d95e321596279f3e8fcf1ad1f04508f48552e2 doc_id: 1018712 cord_uid: kfaegi46 BACKGROUND: The revised definition of sepsis is life‐threatening organ dysfunction caused by a dysregulated host response to infection (SEPSIS‐3). The objective of this study was to evaluate procalcitonin (PCT) for the diagnosis and prognosis of sepsis using SEPSIS‐3. METHODS: We enrolled 248 patients, who were admitted to the emergency department with suspected bacterial infection from June 2016 to February 2017. Definite bacterial infection was defined by proven culture results, and probable bacterial infection was based on diagnostic modalities other than culture. The sequential organ failure assessment (SOFA) score of 2 points or more from the baseline was diagnosed as sepsis. PCT was measured by the AFIAS‐6 immunoassay system (Boditech Med Inc.) using whole blood. White blood cell (WBC), C‐reactive protein (CRP), and erythrocyte sedimentation rate (ERS) were evaluated. RESULTS: The final diagnosis was sepsis in 185 patients with infection of respiratory and genitourinary tract constituted 84.6%. The area under the receiver operating characteristic curve (AUROC) with 95% confidence interval (CI) was as follows: PCT, 0.682 (0.589‐0.765); CRP, 0.583 (0.487‐0.673); ESR, 0.540 (0.515‐0.699); and WBC, 0.611 (0.455‐0.633), respectively. In multivariate analysis, age, SOFA, and PCT (log scale) predicted non‐survivors with an odds ratio with 95% confidence interval of 1.055 (1.008‐1.105), 1.303 (1.142‐1.486), and 2.004 (1.240‐3.238), respectively. Among sepsis group, initial PCT was increased in non‐survivor (23.2 ng/dL) compared to survivor group (8.1 ng/dL) with statistical significance (P = .005). CONCLUSIONS: PCT could support and predict the unfavorable prognosis of sepsis based on SEPSIS‐3, whereas diagnostic potential of PCT requires further evaluations. The original concept of sepsis, which was defined as a systemic inflammatory response syndrome (SIRS) with documented microbial infection, has been used for more than two decades. 1 This definition was revised in part due to an improved understanding of the pathobiology of sepsis. [2] [3] [4] Sepsis is now regarded as early activation of both pro-and anti-inflammatory responses with involvement of non-immunologic systems including cardiovascular, endocrine, and coagulation. 5 In addition, the low diagnostic capability of SIRS led to a revision of the definition of sepsis, though SIRS criteria might still be useful for the identification of infection. 3, 4 The revised definition of sepsis proposed in 2016 (SEPSIS-3) is life-threatening organ dysfunction caused by a dysregulated host response to infection. 5 In brief, former conditions of sepsis and severe sepsis are now regarded as bacterial infection and sepsis, respectively. The revised definition emphasizes organ dysfunction, which can be calculated by sequential organ failure assessment (SOFA) score. The SOFA score-based definition of sepsis predicted mortality higher than that of SIRS-based definition. As infection can lead to organ failure, patients with infection should be carefully followed up. 5 For ease of application in clinical environments, the laboratory data included in SOFA score were bilirubin, creatinine, and platelet count. There have been continuous attempts to diagnosis of SIRS, sepsis, and severe sepsis using biomarkers, especially procalcitonin (PCT), C-reactive protein (CRP), white blood cell (WBC), erythrocyte sedimentation rate (ESR), and various interleukins. [6] [7] [8] PCT and biomarkers are debated for the usefulness and clinical application, but the previous literatures revealed that PCT could support the clinical diagnosis and treatment of patients. Among these biomarkers, PCT and CRP were included in the diagnostic criteria of inflammatory variables in Surviving Sepsis Campaign 2013. 9 However, in the Surviving Sepsis Campaign 2016, PCT was revised to be a recommended biomarker for sepsis prognosis but not for diagnosis. 10 Both diagnosis and prognosis are important in sepsis, and several biomarkers including PCT, sTREM-1, presepsin, and cytokines have been studied for predicting prognosis under former definition of sepsis. 7, [11] [12] [13] [14] In addition, PCT is related to antimicrobial stewardship, a treatment that encompasses initiation and tapering of antimicrobial treatment. 15, 16 The biomarkers evaluated for previously defined severe sepsis might not reflect the performance in revised sepsis due to differences in the details of definitions. In addition, diagnosis of sepsis was revised suing SOFA score, which requires three clinical variables and three laboratory variables, leading to a score range from zero to 24 . We hypothesized that the PCT, CRP, WBC, and ESR might result in capabilities to diagnose sepsis and reflect prognosis. Diagnostic capability of biomarkers could be evaluated by the area under the receiver operating characteristic curve (AUROC) value, and prognostic capability of biomarkers could be evaluated by univariate and multivariate analysis. Therefore, in this study, we evaluated accessible biomarkers including PCT, CRP, ESR, and WBC in the clinical setting for their utility in the diagnosis and prognosis of revised sepsis. This was a single-center study performed at a tertiary teaching hospital, and the study protocol was approved by the institutional review board of Incheon St. Mary's Hospital. Individual consent was not required by the institutional review board because the data were obtained during the course of diagnosis and treatment. Among enrolled patients, data on the following component of SOFA score were collected and graded: PaO 2 /FiO 2 (mm Hg), platelet count, bilirubin, Glasgow Coma Scale (GCS) score, creatinine or renal output level, and mean arterial pressure. The mean arterial pressure was calculated as follows: diastolic blood pressure -1/3 × (systolic blood pressure -diastolic blood pressure). Enrolled patients with suspected bacterial infection and SOFA score of 2 points or more from the baseline were diagnosed with sepsis. 5 Routine microbiological examination included more than two pair of blood cultures. Samples were cultured using two sets of aerobic and anaerobic bottles (BACTEC plus). BACTEC automated blood culture system (BD Biosciences) was used for incubation for 5 days. 21 Culture and analysis of various body fluids (urine, sputum, broncho-alveolar lavage fluid, cerebrospinal fluid, abscess, and closed wound) were performed. Blood samples for WBC counts, ESR, PCT, CRP, and blood chemistry were drawn immediately after presentation to the emergency department and were analyzed in a central laboratory within 2 hours. Hematologic parameters including WBC were measured by Sysmex XN2000 (Sysmex). High-sensitivity C-reactive protein (CRP) within-laboratory, 14.2%, 12.3%, respectively (Table S2) . 22 The limit of blank and limit of detection provided by the manufacturer were 0.044 and 0.066 ng/mL. The claimed analytical measurement range was from 0.1 ng/mL to 100 ng/mL. Cut-off value provided by the manufacturer was 0.5 ng/mL. The cohort consisted of 248 patients diagnosed with suspected bacterial infection who were initially admitted to the emergency department. Of the 248 patients, 63 were classified as the non-sepsis group and 185 as sepsis group. Table 1 shows a comparison of demographic and baseline data between the non-sepsis group and the sepsis group. The mean age, PCT, and WBC of patients in the sepsis group were significantly higher than that of patients in the non-sepsis group. The identified bacteria or other microorganisms are listed in detail in Table S1 . Among the identified microbes, Escherichia coli (21.8%) was the most common pathogen, followed by Klebsiella species (13.8%) and Staphylococcus aureus (11.6%). The ROC curves for PCT, CRP, ESR level, and WBC count for diagnosis of sepsis are shown in Figure 1 . Among the age, sex, and biomarkers, age, PCT, WBC, and SOFA score revealed statistical significance in univariate analysis (Table 3A) . With these variables, multivariate analysis was performed. Among them, age, SOFA score, and PCT (log scale) predicted non-survivors with statistical significance in multivariate analysis (Table 3B ). Comparison of survivor (n = 159) and non-survivor (n = 26) was performed among sepsis group (Table 4) . PCT was higher in non-survivor group compared to survivor group. Among tested markers, only PCT revealed statistical significance (P = .005). Hemoglobin was lower in non-survivor group. Most of SOFA score components revealed statistical significance except for the platelets and bilirubin. severe sepsis revealed higher sensitivity and specificity of 92.0% and 84.0%, respectively, compared with those of SOFA and qSOFA. 16, 24 SIRS criteria might be useful for earlier signs of infection before development of organ dysfunction. 16, 24 The diagnosis of sepsis depends on SOFA score that is the re- The revised sepsis definition includes immune dysregulation, which requires to be measured. Some cytokines are suspected to be related to immune dysregulation, and the exact pathobiology must be identified. Cytokines or immune-regulated molecules are complex, and network analysis might reveal pathobiology. Network analysis revealed that the sepsis network was small in size and path length was short, 31 which might reflect immune dysregulation. PCT was one of the molecules that were the hub node among sepsis network, 31 which implies that PCT is expected to play an important role among cytokine network in sepsis and interacted with other molecules. The limitation of this study was that approximately 80% of patients were diagnosed with respiratory tract and genitourinary tract infection, which might differ from conditions in other hospital intensive care units or emergency departments. Age was increased in sepsis group, and age was one of the prognostic factors that predicted unfavorable prognosis. This was a single-center study, and patient population might have affected the prevalence of sepsis group. In conclusion, under the revised definition of sepsis, PCT could support prognosis of sepsis and predicted mortality compared with other parameters. Further studies are required to accumulate data on PCT using the revised sepsis definition for patient diagnosis and management. We thank emergency department and laboratory department staff for supporting this study. We thank Sungyeon Lee, Chankyu Kim, and Se Woon Cho for excellent technical assistance. Dong Wook Jekarl https://orcid.org/0000-0002-6269-5501 Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Severe sepsis and septic shock Systemic inflammatory response syndrome criteria in defining severe sepsis Assessment of clinical criteria for sepsis for the third international consensus definitions for sepsis and septic shock (Sepsis-3) The third international consensus definitions for sepsis and septic shock Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systemic review and meta-analysis Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 Surviving sepsis campaign: international guidelines for management of sepsis and septic shock Procalcitonin levels in survivors and nonsurvivors of sepsis: systematic review and meta-analysis Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related blood stream infections in selected critically ill patients: a prospective observational study Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis The international sepsis forum consensus conference of definitions of infection in the intensive care unit Evaluation of a multiplex rel-time PCR assay for the detection of respiratory viruses in clinical specimens Diagnosis of liver fibrosis with Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA-M2BP) among chronic hepatitis B patients SCCM/ESICM/ACCP/ ATS/SIS International sepsis definitions conference Comparison of the Bactec Fx Plus, Mycosis IC/F, Mycosis/F Lytic blood culture media and the BacT/ Alert 3D FA media for detection of Candida species in seeded blood culture specimens containing therapeutic peak levels of fluconazole Analytical evaluation and clinical application of insulin and C-peptide by a whole blood, lateral flow, point of care (POC) assay system Serial Procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin monitoring sepsis (MOSES) study Diagnosing sepsis: a step forward, and possibly as step back Diagnostic and prognostic biomarkers of sepsis in critical care Diagnostic and prognostic utility of soluble CD14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis Procalcitonin as diagnostic biomarker of sepsis Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and midregional pro-adrenomedullin Cytokine and molecular networks in sepsis cases: a network biology approach Additional supporting information may be found online in the Supporting Information section at the end of the article. How to cite this article